Abstract
Current clinical brain tumour therapy practices are based on tumour resection and post-operative chemotherapy or X-ray radiation. Resection requires technically challenging open-skull surgeries that can lead to major neurological deficits and, in some cases, death. Treatments with X-ray and chemotherapy, on the other hand, cause major side-effects such as damage to surrounding normal brain tissues and other organs. Here we report the development of an integrated nanomedicine–bioelectronics brain–machine interface that enables continuous and on-demand treatment of brain tumours, without open-skull surgery and toxicological side-effects on other organs. Near-infrared surface plasmon characteristics of our gold nanostars enabled the precise treatment of deep brain tumours in freely behaving mice. Moreover, the nanostars’ surface coating enabled their selective diffusion in tumour tissues after intratumoral administration, leading to the exclusive heating of tumours for treatment. This versatile remotely controlled and wireless method allows the adjustment of nanoparticles’ photothermal strength, as well as power and wavelength of the therapeutic light, to target tumours in different anatomical locations within the brain.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Plasmonics for neuroengineering
Communications Materials Open Access 22 November 2023
-
NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor
Nature Communications Open Access 17 October 2023
-
Design and evaluation of multi-core raspberry-like platinum nanoparticles for enhanced photothermal treatment
Communications Materials Open Access 11 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




Data availability
The data supporting the findings of this study are available within the paper and its Supplementary Information files and are available from the corresponding authors upon reasonable request.
Code availability
The custom script prepared for the wireless photothermal therapy performed in this study is available to download from https://osf.io/5vqxc/.
References
Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 22, iv1–iv96 (2020).
Stupp, R. et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318, 2306–2316 (2017).
Kok, H. P. et al. Heating technology for malignant tumors: a review. Int. J. Hyperth. 37, 711–741 (2020).
Bastiancich, C., Da Silva, A. & Esteve, M. A. Photothermal therapy for the treatment of glioblastoma: potential and preclinical challenges. Front. Oncol. 10, 610356 (2020).
Pinto, A. & Pocard, M. Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review. Pleura Peritoneum 3, 20180124 (2018).
Wei, Q. et al. Intraoperative assessment and photothermal ablation of the tumor margins using gold nanoparticles. Adv. Sci. 8, 2002788 (2021).
Pinel, S., Thomas, N., Boura, C. & Barberi-Heyob, M. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv. Drug Deliv. Rev. 138, 344–357 (2019).
Vines, J. B., Yoon, J. H., Ryu, N. E., Lim, D. J. & Park, H. Gold nanoparticles for photothermal cancer therapy. Front. Chem. 7, 167 (2019).
Chatterjee, H., Rahman, D. S., Sengupta, M. & Ghosh, S. K. Gold nanostars in plasmonic photothermal therapy: the role of tip heads in the thermoplasmonic landscape. J. Phys. Chem. C 122, 13082–13094 (2018).
Vo-Dinh, T. et al. Shining gold nanostars: from cancer diagnostics to photothermal treatment and immunotherapy. J. Immunol. Sci. 2, 1–8 (2018).
Arami, H. et al. Nanomedicine for spontaneous brain tumors: a companion clinical trial. ACS Nano 13, 2858–2869 (2019).
Kim, T. I. et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340, 211–216 (2013).
Montgomery, K. L. et al. Wirelessly powered, fully internal optogenetics for brain, spinal and peripheral circuits in mice. Nat. Methods 12, 969–974 (2015).
Park, S. I. et al. Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics. Nat. Biotechnol. 33, 1280–1286 (2015).
Kang, S. K. et al. Bioresorbable silicon electronic sensors for the brain. Nature 530, 71–76 (2016).
Chung, H. U. et al. Binodal, wireless epidermal electronic systems with in-sensor analytics for neonatal intensive care. Science 363, eaau0780 (2019).
Lee, Y. & Kim, D. H. Wireless metronomic photodynamic therapy. Nat. Biomed. Eng. 3, 5–6 (2019).
Yamagishi, K. et al. Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy. Nat. Biomed. Eng. 3, 27–36 (2019).
Agrawal, D. R. et al. Conformal phased surfaces for wireless powering of bioelectronic microdevices. Nat. Biomed. Eng. 1, 0043 (2017).
Bansal, A., Yang, F., Xi, T., Zhang, Y. & Ho, J. S. In vivo wireless photonic photodynamic therapy. Proc. Natl Acad. Sci. USA 115, 1469–1474 (2018).
Ho, J. S. et al. Self-tracking energy transfer for neural stimulation in untethered mice. Phys. Rev. Appl. 4, 024001 (2015).
Wang, M., Kim, M., Xia, F. & Xu, C. Impact of the emission wavelengths on in vivo multiphoton imaging of mouse brains. Biomed. Opt. Express 10, 1905–1918 (2019).
Stujenske, J. M., Spellman, T. & Gordon, J. A. Modeling the spatiotemporal dynamics of light and heat propagation for in vivo optogenetics. Cell Rep. 12, 525–534 (2015).
Lee, P. M., Tian, X. & Ho, J. S. Wireless power transfer for glioblastoma photodynamic therapy. In 2019 IEEE Biomedical Circuits and Systems Conference (BioCAS) 1–4 (IEEE, 2019).
US Federal Communications Commission. 47 CFR 1.1310, Radiofrequency radiation exposure limits (Federal Communications Commission, Washington, DC, 2011).
Ash, C., Dubec, M., Donne, K. & Bashford, T. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med. Sci. 32, 1909–1918 (2017).
Gutruf, P. et al. Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal models. Nat. Commun. 10, 5742 (2019).
Shin, G. et al. Flexible near-field wireless optoelectronics as subdermal implants for broad applications in optogenetics. Neuron 93, 509–521.e3 (2017).
Kim, A. et al. An implantable ultrasonically-powered micro-light-source (µLight) for photodynamic therapy. Sci. Rep. 9, 1395 (2019).
Tajima, K. et al. Wireless optogenetics protects against obesity via stimulation of non-canonical fat thermogenesis. Nat. Commun. 11, 1730 (2020).
Holland, J. M., Mitchell, T. J., Gipson, L. C. & Whitaker, M. S. Survival and cause of death in aging germfree athymic nude and normal inbred C3Hf/He mice. J. Natl Cancer Inst. 61, 1357–1361 (1978).
Simpson, J. R. et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26, 239–244 (1993).
Hettie, K. S., Teraphongphom, N. T., Ertsey, R. D., Rosenthal, E. L. & Chin, F. T. Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection. RSC Adv. 10, 42413–42422 (2020).
Chang, E. et al. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models. J. Neurooncol. 126, 253–264 (2016).
Won, S. M., Song, E., Reeder, J. T. & Rogers, J. A. Emerging modalities and implantable technologies for neuromodulation. Cell 181, 115–135 (2020).
Kim, J., Campbell, A. S., de Avila, B. E. & Wang, J. Wearable biosensors for healthcare monitoring. Nat. Biotechnol. 37, 389–406 (2019).
Yang, J. C. et al. Electronic skin: recent progress and future prospects for skin-attachable devices for health monitoring, robotics, and prosthetics. Adv. Mater. 31, e1904765 (2019).
Pucci, C., Martinelli, C. & Ciofani, G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience 13, 961 (2019).
Murty, S. et al. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. OncoImmunology 9, 1757360 (2020).
Tavares, A. J. et al. Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc. Natl Acad. Sci. USA 114, E10871–E10880 (2017).
Acknowledgements
We acknowledge support from the Center for Cancer Nanotechnology Excellence and Translation at NCI-NIH (grant no. 1U54CA199075) and NIH grants (NCI 1R01CA199656-01A1 and 1R01 222836-01). H.A. was supported by NIH National Cancer Institute K99/R00 Pathway to Independence award (grant no. 1K99CA234208-01A1) and NIH T32 CA009695 (Stanford Cancer Imaging Training, SCIT). L.K. acknowledges support from the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) K99/R00 Pathway to Independence award (grant no. 1K99EB031178-01) and NIH T32 CA196585 (Cancer-Translational Nanotechnology Training (Cancer-TNT) program) at Stanford University. C.B.P. is a McNair Scholar supported by the McNair Medical Institute at The Robert and Janice McNair Foundation. We thank I. V. Balyasnikova at Northwestern University and M. D. Ferro at Stanford University for providing the U87-GFP-Fluc cells and assistance with parylene coating, respectively. Additionally, we acknowledge CST for providing access to the 3D full-wave simulator (CST Studio Suite). We also thank support and guidance from J. Rao and H. Daldrup-Link at Stanford Department of Radiology that enabled us to complete this study. This paper is dedicated to Dr. Sanjiv Sam Gambhir, who we lost to cancer during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
H.A. developed the idea, carried out or supervised all the experiments, analysed the data and wrote the manuscript. H.A., S.K. and L.K. designed the project and experiments and contributed to the data analysis and manuscript revision. C.B.P., E.C. and A.N. contributed to the animal experiments, imaging and histological data analysis. E.E.P. helped with tissue processing and histological experiments. Y.T. and A.S.Y.P discussed and supervised the design of the wireless systems. Y.Z., S.J.M. and R.S. performed the SEM measurements. M.J.M. contributed in designing the optical devices. All the authors reviewed and commented on the manuscript. S.S.G. and A.S.Y.P discussed and supervised the experiments and manuscript preparation.
Corresponding authors
Ethics declarations
Competing interests
The authors declare the following competing interests: A.S.Y.P. and Y.T. co-founded Aeterlink and Vivonda Medical commercializing wireless powering technology. H.A., S.K., L.K., M.J.M., A.S.Y.P. and S.S.G are the co-inventors of a patent covering this study filed by Stanford University. All the other authors have no competing interests.
Peer review
Peer review information
Nature Nanotechnology thanks Constantinos Hadjipanayis, John Ho and Rodney O’Connor for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Figs. 1–48 and text.
Supplementary Video 1
Freely behaving mice under wireless photothermal therapy.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arami, H., Kananian, S., Khalifehzadeh, L. et al. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nat. Nanotechnol. 17, 1015–1022 (2022). https://doi.org/10.1038/s41565-022-01189-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-022-01189-y
This article is cited by
-
A general methodology to measure the light-to-heat conversion efficiency of solid materials
Light: Science & Applications (2023)
-
Design and evaluation of multi-core raspberry-like platinum nanoparticles for enhanced photothermal treatment
Communications Materials (2023)
-
The blood–brain barrier: structure, regulation, and drug delivery
Signal Transduction and Targeted Therapy (2023)
-
Plasmonics for neuroengineering
Communications Materials (2023)
-
NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor
Nature Communications (2023)